AGTC to Present at Upcoming Investor Conferences
August 05, 2014 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
August 04, 2014 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Aug. 4, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC) announced today the closing on July 30, 2014 of its public offering of 2,000,000 shares of...
AGTC Announces Pricing of Public Offering
July 24, 2014 19:05 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., July 24, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC) today announced the pricing of its public offering of 2,000,000 shares of its common stock...
AGTC Appoints Matthew Feinsod, MD, as Product Development Officer
July 01, 2014 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., July 1, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Appoints David R. Guyer, MD, and Ivana Magovcevic-Liebisch, PhD, JD, to Its Board of Directors
June 30, 2014 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., June 30, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC and SAFC Create Strategic Partnership to Provide Gene Therapy Manufacturing Services
June 24, 2014 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CARLSBAD, Calif., June 24, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated...
AGTC to Present at Upcoming Investor Conferences
June 05, 2014 16:42 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., June 5, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Announces Financial Results for the Quarter and Nine Months Ended March 31, 2014
May 14, 2014 16:39 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., May 14, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Data Presented at the ARVO Annual Meeting Support Development of Gene-Based Therapies for Achromatopsia
May 05, 2014 11:24 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., May 5, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Announces Presentation at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
May 02, 2014 09:20 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., May 2, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...